Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Continuing ACE Inhibitors/ARBs Before CABG on Postoperative Acute Kidney Injury
TCTR20210824011Not yet recruiting
- Sponsor
- N/A
- Start
- Aug 2021
- Countries
- 1
01
Overview
Open-label trial in coronary arteriosclerosis (2 arms), sponsored by N/A. Primary endpoint: Incidence of postoperative acute kidney injury. Planned start Aug 2021; status: not yet recruiting.
02
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20210824011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210824011.